Metagenomi Inc., a precision genetic medicines company, will present at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting in New Orleans, LA, and virtually from May 13-17, 2025. They will showcase three poster presentations, including one titled "A Compact and Potent Type II CRISPR System for CNS Gene Knockdown via AAV Delivery," on Tuesday, May 13, 2025, at 6:00 p.m. CT in Poster Hall I2.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.